Malignant pericardial effusion in diseases classified elsewhere
ICD-10 I31.31 is a billable code used to indicate a diagnosis of malignant pericardial effusion in diseases classified elsewhere.
Malignant pericardial effusion refers to the accumulation of fluid in the pericardial space due to malignancies, often associated with cancers such as lung, breast, or hematological malignancies. Clinically, patients may present with symptoms such as dyspnea, chest pain, or signs of cardiac tamponade, which can lead to hemodynamic instability. The pericardium, a double-walled sac surrounding the heart, can become inflamed or compromised due to the underlying malignancy, leading to fluid accumulation. Disease progression can vary; some patients may experience rapid accumulation of fluid, while others may have a more gradual onset. Diagnostic considerations include echocardiography, which is the primary imaging modality used to assess pericardial effusion, and may be complemented by CT or MRI for further evaluation. Additionally, pericardiocentesis may be performed both for diagnostic and therapeutic purposes, allowing for fluid analysis and symptom relief. Accurate diagnosis and management are crucial, as malignant pericardial effusion can significantly impact the patient's prognosis and quality of life.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I31.31 covers malignant pericardial effusion resulting from various malignancies, including lung cancer, breast cancer, and hematological malignancies such as lymphoma or leukemia. It is essential to document the underlying malignancy to support the use of this code.
I31.31 should be used when the pericardial effusion is specifically due to a malignancy. If the effusion is due to non-malignant causes, other codes such as I31.0 should be utilized. Accurate differentiation is crucial for proper coding.
Documentation should include the diagnosis of the underlying malignancy, clinical findings related to the pericardial effusion, results from imaging studies, and any procedures performed such as pericardiocentesis. Detailed notes on the patient's symptoms and treatment plan are also essential.
